COPD Trial, Recruiting NCT04860375 Sponsor: Vastra Gotaland Region Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT04860375
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 40 years or older, of any gender
  • People who are current smokers or ex-smokers with a significant smoking history (at least 10 "pack-years," which is roughly the equivalent of smoking one pack a day for 10 years)
  • People who have previously been admitted to hospital due to worsening breathlessness (with or without increased coughing, mucus, or discoloured mucus), where doctors suspected a COPD flare-up serious enough to refer them to a COPD specialist centre
  • People who have signed a consent form agreeing to take part in the trial

Who may not be able to join:

  • People whose hospital visit for similar symptoms was found by doctors to be caused by something other than a COPD flare-up, such as chest injury, neurological conditions, severe infection, cancer, or anaemia
  • People who are already enrolled in another study that may interfere with this one
  • People for whom a breathing test called spirometry is not safe to perform — for example, those with coughing up blood, a detached retina, or active tuberculosis
  • People who, in the trial team's opinion, would not be able to follow the study procedures and attend follow-up appointments — for example, due to another serious illness, alcohol or drug issues, dementia, or a severe psychiatric condition
  • People who have recently had a heart attack, unstable chest pain, or a heart rhythm problem requiring specialised heart care
  • People who have been diagnosed with a stroke, dementia, a progressive neurological condition, or a psychiatric disorder that requires specialist care
  • People whom the recruiting doctor considers unsuitable for the study for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lowie Vanfleteren, COPD-center, Sahlgrenska University Hospital

Phone: 0046736601730

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Vastra Gotaland Region
Registry
ClinicalTrials.gov
Start date
22 September 2021
Est. completion
31 December 2028

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Total number of hospitalizations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov